相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商:
齐源
- 库存:
999
- 靶点:
IgD
- 级别:
mouse IgD Antibody
- 目录编号:
mouse IgD Antibody
- 克隆性:
单克隆
- 抗原来源:
大鼠
- 保质期:
mouse IgD Antibody
- 抗体英文名:
Purified anti-mouse IgD Antibody
- 抗体名:
IgD 抗体
- 标记物:
mouse IgD Antibody
- 宿主:
大鼠
- 适应物种:
小鼠
- 免疫原:
mouse IgD Antibody
- 亚型:
mouse IgD Antibody
- 形态:
mouse IgD Antibody
- 应用范围:
FC, IHC-P, IHC-F, ICC
- 保存条件:
2-8℃
- 浓度:
0.5 mg/ml
- 规格:
500 ug
Purified anti-mouse IgD Antibody详细如下:
Description :Surface IgD is an important B cell differentiation marker.
Verified Reactivity :Mouse
Antibody Type :Monoclonal
Host Species :Rat
Formulation :Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation :The antibody was purified by affinity chromatography.
Concentration :0.5 mg/ml
Storage & Handling :The antibody solution should be stored undiluted between 2°C and 8°C.
Application :FC - Quality tested、IHC-P, IHC-F, ICC - Reported in the literature, not verified in house
Recommended Usage :Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometricanalysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cellsin 100 µl volume. It is recommended that the reagent be titrated for optimal performance for eachapplication.
Description :Surface IgD is an important B cell differentiation marker.
Verified Reactivity :Mouse
Antibody Type :Monoclonal
Host Species :Rat
Formulation :Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation :The antibody was purified by affinity chromatography.
Concentration :0.5 mg/ml
Storage & Handling :The antibody solution should be stored undiluted between 2°C and 8°C.
Application :FC - Quality tested、IHC-P, IHC-F, ICC - Reported in the literature, not verified in house
Recommended Usage :Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometricanalysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cellsin 100 µl volume. It is recommended that the reagent be titrated for optimal performance for eachapplication.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
Application References(PubMed link indicatesBioLegend citation):
1. Nitschke L, et al. 1993. P. Natl. Acad. Sci. USA 90:1887. (FC)
2. Weih D, et al. 2001. J. Immunol. 167:1909. (IHC)
3. Koni PA, et al. 2001. J. Exp. Med. 193:741. (IHC)
4. Ahuja A, et al. 2007. J. Immunol. 179:3351. (FC) PubMed
5. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
6. Good-Jacobson KL, et al. 2010. Nat. Immunol. 11:535. (FC) PubMed
7. Tomayko MM, et al. 2010. J. Immunol. 185:7146. PubMed
8. Park SY, et al. 2013. J. Immunol. 190:1094. PubMed
9. Rouaud P, et al. 2014. J Exp Med. 211:975. PubMed
10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations:
1. Niss Arfelt K, et al. 2017. Blood. 129:866. PubMed
2. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
3. van Dinther D, et al. 2019. Cancers (Basel). 0.585416667. PubMed
4. Ahuja A, et al. 2007. J Immunol. 179:3351. PubMed
5. Zhong X, et al. 2020. Proc Natl Acad Sci U S A. 8563:117. PubMed
6. Majer O, et al. 2019. Nature. 575:366. PubMed
7. Park S, et al. 2013. J Immunol. 190:1094. PubMed
8. King IL, et al. 2017. Mucosal Immunol. 10:1160. PubMed
9. Zelazowska MA, et al. 2020. Life Sci Alliance. :3. PubMed
10. Englezou PC, et al. 2018. Mol Ther Nucleic Acids. 12:118. PubMed
11. Tomayko M, et al. 2010. J Immunol. 185:7146. PubMed
12. Paun A, et al. 2021. Blood Adv. 5:745. PubMed
1. Nitschke L, et al. 1993. P. Natl. Acad. Sci. USA 90:1887. (FC)
2. Weih D, et al. 2001. J. Immunol. 167:1909. (IHC)
3. Koni PA, et al. 2001. J. Exp. Med. 193:741. (IHC)
4. Ahuja A, et al. 2007. J. Immunol. 179:3351. (FC) PubMed
5. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
6. Good-Jacobson KL, et al. 2010. Nat. Immunol. 11:535. (FC) PubMed
7. Tomayko MM, et al. 2010. J. Immunol. 185:7146. PubMed
8. Park SY, et al. 2013. J. Immunol. 190:1094. PubMed
9. Rouaud P, et al. 2014. J Exp Med. 211:975. PubMed
10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations:
1. Niss Arfelt K, et al. 2017. Blood. 129:866. PubMed
2. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
3. van Dinther D, et al. 2019. Cancers (Basel). 0.585416667. PubMed
4. Ahuja A, et al. 2007. J Immunol. 179:3351. PubMed
5. Zhong X, et al. 2020. Proc Natl Acad Sci U S A. 8563:117. PubMed
6. Majer O, et al. 2019. Nature. 575:366. PubMed
7. Park S, et al. 2013. J Immunol. 190:1094. PubMed
8. King IL, et al. 2017. Mucosal Immunol. 10:1160. PubMed
9. Zelazowska MA, et al. 2020. Life Sci Alliance. :3. PubMed
10. Englezou PC, et al. 2018. Mol Ther Nucleic Acids. 12:118. PubMed
11. Tomayko M, et al. 2010. J Immunol. 185:7146. PubMed
12. Paun A, et al. 2021. Blood Adv. 5:745. PubMed
文献支持
Purified 抗小鼠 IgD 抗体
¥2800










